pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

23,715 catalysts · 18,987 approval · 7,208 phase readout · 5,000 device 510k · 4,728 grant · 3,603 8k filing · 2,000 device pma

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 1 catalyst2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts2026-11-09: 1 catalyst2026-11-10: 0 catalysts2026-11-11: 0 catalysts2026-11-12: 0 catalysts2026-11-13: 0 catalysts2026-11-14: 0 catalysts2026-11-15: 0 catalysts2026-11-16: 0 catalysts2026-11-17: 0 catalysts2026-11-18: 0 catalysts2026-11-19: 0 catalysts2026-11-20: 0 catalysts2026-11-21: 0 catalysts2026-11-22: 0 catalysts
view
agendamonth
hide past →
sort
soonestlatesttypesponsoralpha
type: approval×type: grant×clear all
type
  • approval18,987
  • phase readout7,208
  • device 510k5,000
  • grant4,728
  • 8k filing3,603
  • device pma2,000
  • device recall
2,000
  • recall1,126
  • device adverse event1,000
  • earnings585
  • therapy area

    no tagged catalysts yet

    Week of Feb 2, 2026

    50
    ›Feb 3, 2026approval208d agoIBANDRONATE SODIUM — FDA approvalIBANDRONATE SODIUM

    Sponsor: ACCORD HLTHCARE. Form: INJECTABLE. Route: INTRAVENOUS

    full page →IBANDRONATE SODIUM →fda approvals ↗
    ›Feb 3, 2026approval208d agoIBANDRONATE SODIUM — FDA approvalIBANDRONATE SODIUM

    Sponsor: MACLEODS PHARMS LTD. Form: TABLET. Route: ORAL

    full page →IBANDRONATE SODIUM →fda approvals ↗
    ›Feb 3, 2026approval208d agoIBANDRONATE SODIUM — FDA approvalDR REDDYS LABORATORIES LTD

    Sponsor: PHARMOBEDIENT. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Feb 3, 2026approval208d agoIBANDRONATE SODIUM — FDA approvalIBANDRONATE SODIUM

    Sponsor: SUN PHARM INDUSTRIES. Form: TABLET. Route: ORAL

    full page →IBANDRONATE SODIUM →fda approvals ↗
    ›Feb 3, 2026approval208d agoIBANDRONATE SODIUM — FDA approvalIBANDRONATE SODIUM

    Sponsor: DR REDDYS LABS LTD. Form: TABLET. Route: ORAL

    full page →IBANDRONATE SODIUM →fda approvals ↗
    ›Feb 3, 2026approval208d agoIBANDRONATE SODIUM — FDA approvalDR REDDYS LABORATORIES LTD

    Sponsor: ORBION PHARMS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Feb 3, 2026approval208d agoIBANDRONATE SODIUM — FDA approvalDR REDDYS LABORATORIES LTD

    Sponsor: PHARMOBEDIENT. Form: INJECTABLE. Route: INTRAVENOUS

    full page →fda approvals ↗
    ›Feb 3, 2026approval208d agoIBANDRONATE SODIUM — FDA approvalDR REDDYS LABORATORIES LTD

    Sponsor: WATSON LABS TEVA. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Feb 3, 2026approval208d agoIBANDRONATE SODIUM — FDA approvalDR REDDYS LABORATORIES LTD

    Sponsor: EUGIA PHARMA. Form: INJECTABLE. Route: INTRAVENOUS

    full page →fda approvals ↗
    ›Feb 3, 2026approval208d agoBINOSTO (ALENDRONATE SODIUM) — FDA approvalOrganon & Co.

    Sponsor: RADIUS. Form: TABLET, EFFERVESCENT. Route: ORAL

    full page →fda approvals ↗
    ›Feb 3, 2026approval208d agoIBANDRONATE SODIUM — FDA approvalIBANDRONATE SODIUM

    Sponsor: APOTEX. Form: INJECTABLE. Route: INTRAVENOUS

    full page →IBANDRONATE SODIUM →fda approvals ↗
    ›Feb 3, 2026approval208d agoIBANDRONATE SODIUM — FDA approvalIBANDRONATE SODIUM

    Sponsor: APOTEX. Form: INJECTABLE. Route: INTRAVENOUS

    full page →IBANDRONATE SODIUM →fda approvals ↗
    ›Feb 3, 2026approval208d agoSTIVARGA (REGORAFENIB) — FDA approvalBayer AG

    Sponsor: BAYER HLTHCARE. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Feb 3, 2026approval208d agoDOXORUBICIN HYDROCHLORIDE — FDA approvalBAXTER INTERNATIONAL INC

    Sponsor: QILU PHARM HAINAN. Form: INJECTABLE, LIPOSOMAL. Route: INJECTION

    full page →fda approvals ↗
    ›Feb 3, 2026approval208d agoACTONEL (RISEDRONATE SODIUM) — FDA approvalAllergan Finance LLC

    Sponsor: APIL. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Feb 3, 2026approval208d agoFOSAMAX PLUS D (ALENDRONATE SODIUM) — FDA approval(alendronate sodium + cholecalciferol)

    Sponsor: ORGANON LLC. Form: TABLET. Route: ORAL

    full page →(alendronate sodium + cholecalciferol) →fda approvals ↗
    ›Feb 3, 2026approval208d agoIBANDRONATE SODIUM — FDA approvalDR REDDYS LABORATORIES LTD

    Sponsor: NANG KUANG PHARM CO. Form: INJECTABLE. Route: INTRAVENOUS

    full page →fda approvals ↗
    ›Feb 3, 2026grant208d agoUNIVERSITY OF PENNSYLVANIA — SHIV-infected rhesus macaques as a model for HIV-1 bNAb developmentUniversity of Pennsylvania

    AI grant. $803,591. PI: GEORGE M SHAW

    full page →nih reporter ↗
    ›Feb 3, 2026grant208d agoUNIVERSITY OF MICHIGAN AT ANN ARBOR — Deciphering Virulence Determinants of Human-Pathogenic Atypical Toxoplasma go...

    AI grant. $411,780. PI: Yifan Wang

    full page →nih reporter ↗
    ›Feb 3, 2026grant208d agoUNIVERSITY OF FLORIDA — Detection of Shigella Species in Wastewater - A Pilot Study for Community and...University of Florida

    AI grant. $422,125. PI: Anthony T Maurelli

    full page →nih reporter ↗
    ›Feb 3, 2026grant208d agoMETHODIST HOSPITAL RESEARCH INSTITUTE — The epigenetic regulation of alloimmune stem-like CD4+ T cells

    AI grant. $491,663. PI: Wenhao Chen

    full page →nih reporter ↗
    ›Feb 3, 2026grant208d agoSLOAN-KETTERING INST CAN RESEARCH — Decoding the role of Aire-expressing Thetis cells in peripheral self-tolerance

    AI grant. $616,042. PI: Chrysothemis Brown

    full page →nih reporter ↗
    ›Feb 3, 2026grant208d agoGEORGE WASHINGTON UNIVERSITY — Genetic determinants of host immunity-mediated resistance to helminth infection

    AI grant. $444,125. PI: PEDRO GAZZINELLI GUIMARAES

    full page →nih reporter ↗
    ›Feb 3, 2026grant208d agoHUGO W. MOSER RES INST KENNEDY KRIEGER — GLOW: Gleaning Language trajectories and Outcomes in autistic toddlers using ...

    DC grant. $818,502. PI: Rachel Reetzke

    full page →nih reporter ↗
    ›Feb 3, 2026grant208d agoUNIVERSITY OF FLORIDA — The role of B cell Cul4b in gammaherpesvirus latency and lymphomaUniversity of Florida

    AI grant. $610,971. PI: Emily K. Moser

    full page →nih reporter ↗
    ›Feb 3, 2026grant208d agoUNIVERSITY OF CALIFORNIA, SAN FRANCISCO — Resilience in Action™ : Assessing the behavioral target mechanisms of the RiA...University of California San Francisco

    MH grant. $863,276. PI: Megumi J Okumura

    full page →nih reporter ↗
    ›Feb 3, 2026grant208d agoUNIVERSITY OF CALIFORNIA LOS ANGELES — Deficits in behavioral time-scale plasticity underlying imprecision and insta...University of California Los Angeles

    NS grant. $236,250. PI: Ahmet ARAC

    full page →nih reporter ↗
    ›Feb 3, 2026grant208d agoRUTGERS BIOMEDICAL AND HEALTH SCIENCES — Contribution of type III Interferons to the pathogenesis of Staphylococcus au...

    AI grant. $762,847. PI: Dane Parker

    full page →nih reporter ↗
    ›Feb 3, 2026grant208d agoVANDERBILT UNIVERSITY — Engineering Extracellular Vesicles for Tolerogenic Immunotherapy

    AI grant. $448,089. PI: John Tanner Wilson

    full page →nih reporter ↗
    ›Feb 3, 2026grant208d agoHENRY FORD HEALTH + MICHIGAN STATE UNIVERSITY HEALTH SCIENCES — Computationally predicting bacterial strain susceptibility to phages

    AI grant. $435,379. PI: Janani Ravi

    full page →nih reporter ↗
    ›Feb 3, 2026grant208d agoSTATE UNIVERSITY OF NEW YORK AT ALBANY — A-rich function for the Zika virus 3' untranslated region

    AI grant. $227,115. PI: Cara Theresia Pager

    full page →nih reporter ↗
    ›Feb 3, 2026grant208d agoICAHN SCHOOL OF MEDICINE AT MOUNT SINAI — A Comprehensive Genetic, Transcriptomic, and Immunohistochemical Analysis of PSP

    NS grant. $669,891. PI: Kurt William Farrell

    full page →nih reporter ↗
    ›Feb 3, 2026grant208d agoTEXAS TECH UNIVERSITY — Population dynamics at an invasive front: Aedes aegypti in the American South...

    AI grant. $648,891. PI: Joseph Richard McMillan

    full page →nih reporter ↗
    ›Feb 3, 2026grant208d agoMASSACHUSETTS GENERAL HOSPITAL — A tissue-based approach to understanding TB-associated lung fibrosisMassachusetts General Hospital

    AI grant. $798,107. PI: Amy K Barczak

    full page →nih reporter ↗
    ›Feb 3, 2026grant208d agoUNIVERSITY OF CALIFORNIA, SAN DIEGO — Investigating the Role of Tanycyte Barriers at the Circumventricular Organs i...University of California San Diego

    NS grant. $121,554. PI: Sidar Aydin

    full page →nih reporter ↗
    ›Feb 3, 2026grant208d agoGEORGE WASHINGTON UNIVERSITY — Cross-class selection for anthelmintic resistance in the hookworm Ancylostoma...

    AI grant. $444,125. PI: JOHN M HAWDON

    full page →nih reporter ↗
    ›Feb 3, 2026grant208d agoUNIVERSITY OF MARYLAND BALTIMORE — A cord-blood specific subset of human gamma-delta T cells with distinct funct...

    AI grant. $455,500. PI: Cristiana Cairo

    full page →nih reporter ↗
    ›Feb 3, 2026grant208d agoRUTGERS BIOMEDICAL AND HEALTH SCIENCES — Novel metabolite-derived anorexigens in infection

    AI grant. $431,750. PI: George S. Yap

    full page →nih reporter ↗
    ›Feb 3, 2026grant208d agoNEW YORK UNIVERSITY SCHOOL OF MEDICINE — Regulation of CD4+ and CD8+ T cell function by CLNS1ANew York University

    AI grant. $755,801. PI: STEFAN FESKE

    full page →nih reporter ↗
    ›Feb 3, 2026grant208d agoNEW YORK UNIVERSITY SCHOOL OF MEDICINE — Perivascular macrophages control the severity of experimental autoimmune ence...New York University

    AI grant. $466,125. PI: Juan Lafaille

    full page →nih reporter ↗
    ›Feb 3, 2026grant208d agoUNIVERSITY OF ILLINOIS AT CHICAGO — Identifying inhibitors of the bacterial peptidyl-tRNA hydrolase

    AI grant. $440,908. PI: Paul R Carlier

    full page →nih reporter ↗
    ›Feb 3, 2026grant208d agoUNIVERSITY OF CALIFORNIA, SAN FRANCISCO — EXPanding Access to Neurosurgery reSearch Education (EXPANSE)University of California San Francisco

    NS grant. $264,746. PI: Shawn L. Hervey-Jumper

    full page →nih reporter ↗
    ›Feb 4, 2026approval207d agoATROPINE SULFATE — FDA approvalATROPINE SULFATE

    Sponsor: ACCORD HLTHCARE. Form: SOLUTION. Route: INTRAVENOUS

    full page →ATROPINE SULFATE →fda approvals ↗
    ›Feb 4, 2026approval207d agoCARBOPLATIN — FDA approvalOncotelic Therapeutics, Inc.

    Sponsor: QILU PHARM HAINAN. Form: INJECTABLE. Route: INTRAVENOUS

    full page →fda approvals ↗
    ›Feb 4, 2026grant207d agoUNIVERSITY OF CALIFORNIA, SAN DIEGO — Discovery and evolution of mammalian Serpins as host-encoded viral protease i...University of California San Diego

    AI grant. $439,250. PI: Matthew Daugherty

    full page →nih reporter ↗
    ›Feb 4, 2026grant207d agoDUKE UNIVERSITY — BCG-Mediated Immunotherapy Against BacteriaDuke University

    AI grant. $610,124. PI: Soman N Abraham

    full page →nih reporter ↗
    ›Feb 4, 2026grant207d agoUNIV OF MARYLAND, COLLEGE PARK — Longitudinal Mixed Methods Analysis of Risk and Protective Factors Influencin...

    HD grant. $35,832. PI: Pond Ezra

    full page →nih reporter ↗
    ›Feb 4, 2026grant207d agoTUFTS UNIVERSITY BOSTON — Characterization and treatment of an accelerated aging model of the olfactory...

    DC grant. $779,636. PI: Brian Lin

    full page →nih reporter ↗
    ›Feb 4, 2026grant207d agoNORTH CAROLINA AGRI & TECH ST UNIV — Biomarkers for Whole Grain Intake and Cardiometabolic Health

    DK grant. $765,558. PI: Shengmin Sang

    full page →nih reporter ↗
    ›Feb 4, 2026grant207d agoUNIVERSITY OF PITTSBURGH AT PITTSBURGH — A rationally designed phage cocktail to treat MDR P. aeruginosa infections

    AI grant. $437,250. PI: Ryan K Shields

    full page →nih reporter ↗
    ← prev
    page 423 of 475
    next →
    $BAX26.13+0.81%
    $RDY12.18+0.16%
    $OGN13.760.00%
    $OGN13.760.00%
    $RDY12.18+0.16%
    $RDY12.18+0.16%
    $RDY12.18+0.16%
    $RDY12.18+0.16%
    $RDY12.18+0.16%
    $RDY12.18+0.16%
    $OTLC0.0373-8.80%